Clinical Trial Biorepository and Archiving Solutions Market Report 2026

The clinical trial biorepository and archiving solutions market size has grown strongly in recent years. It will grow from $4.43 billion in 2025 to $4.79 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to growth in clinical trial volumes, increasing regulatory documentation requirements, expansion of pharmaceutical r&d activities, rise in biobanking practices, globalization of clinical research.

The clinical trial biorepository and archiving solutions market size is expected to see strong growth in the next few years. It will grow to $6.54 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increase in precision medicine trials, growing biopharmaceutical pipelines, rising need for long-term sample retention, expansion of decentralized clinical trials, stricter regulatory audit requirements. Major trends in the forecast period include growing demand for long-term biospecimen storage, rising importance of regulatory-compliant archiving, expansion of global clinical trial activities, increasing use of centralized biorepositories, focus on data integrity and sample traceability.

The rising volume of clinical trials is poised to fuel expansion in the clinical trial biorepository and archiving solutions market moving forward. Clinical trials involve research studies on human participants to evaluate the safety, efficacy, and adverse effects of novel medical treatments or drugs. This surge in trials stems from progress in medical research and the rise of personalized medicine, which demands more precise and varied testing. Clinical trial biorepository and archiving solutions support this growth by providing secure, long-term storage for biological samples, straightforward access, and adherence to regulatory requirements, thereby boosting data integrity and speeding up subsequent studies. For example, in December 2024, the Association of the British Pharmaceutical Industry (ABPI), a UK-based group, reported that industry-sponsored clinical trial activity in the UK increased for the second year running, climbing from 411 trials in 2022 to 426 in 2023. Thus, the growing number of clinical trials is propelling the clinical trial biorepository and archiving solutions market.

Major companies in the clinical trial biorepository and archiving solutions market are prioritizing the creation of innovative solutions, like advanced biorepository facilities, to enhance storage, data management, and compliance in clinical research. A state-of-the-art biorepository facility is an advanced center for storage and management, featuring cutting-edge technology to preserve biological samples and clinical trial data. For example, in January 2025, Azenta Life Sciences, a US-based biotech firm, opened a cutting-edge biorepository facility in Greater Boston to aid the biotech and life sciences sectors with sophisticated sample storage and management. This facility supports streamlined handling of research, clinical trials, and biobanking, while providing secure, compliant offsite storage options for clinical trials.

In July 2024, Tobin Scientific Inc., a US-based provider of laboratory services, biopharma cold chain, ambient storage, transport, and logistics solutions, acquired BioRepository Resources LLC for an undisclosed sum. Through this acquisition, Tobin Scientific Inc. seeks to bolster its biopharmaceutical storage capabilities, broaden its market reach, and solidify its leadership in the life sciences sector. BioRepository Resources LLC, a US-based life sciences service provider, specializes in clinical trial biorepository and archiving solutions.

Major companies operating in the clinical trial biorepository and archiving solutions market are Thermo Fisher Scientific Inc., GE HealthCare, Labcorp Holdings Inc., IQVIA, ICON plc, Avantor Inc., VWR International LLC, Charles River Laboratories, Parexel, Clinigen Limited, Inotiv Inc., Medpace Holdings Inc., LabConnect LLC, Azenta Life Sciences, HSRL Holdings LLC, EPL Archives, Manuh Solutions LLC, EMINENT Services Corporation, Boca Biolistics LLC, Astoriom.

North America was the largest region in the clinical trial biorepository and archiving solutions market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical trial biorepository and archiving solutions market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the clinical trial biorepository and archiving solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have affected the clinical trial biorepository and archiving solutions market by increasing the cost of imported storage equipment, cryogenic systems, monitoring devices, and specialized consumables. These impacts have been most pronounced in temperature-controlled storage and archiving infrastructure segments, particularly in north america and europe where equipment sourcing is globally diversified. Asia-pacific service providers have faced cost pressures due to imported hardware dependencies. However, tariffs have encouraged regional infrastructure development and local equipment sourcing, strengthening operational resilience.

The clinical trial biorepository and archiving solutions market research report is one of a series of new reports that provides clinical trial biorepository and archiving solutions market statistics, including clinical trial biorepository and archiving solutions industry global market size, regional shares, competitors with a clinical trial biorepository and archiving solutions market share, detailed clinical trial biorepository and archiving solutions market segments, market trends and opportunities, and any further data you may need to thrive in the clinical trial biorepository and archiving solutions industry. This clinical trial biorepository and archiving solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Clinical trial biorepository and archiving solutions provide services for managing the collection, storage, preservation, and retrieval of biological samples, clinical data, and related documentation throughout and beyond clinical trials. These solutions guarantee that biospecimens remain stored in regulated conditions, preserving their integrity for subsequent research, regulatory audits, or further analysis.

The primary clinical trial biorepository and archiving solution products consist of preclinical products and clinical products. Preclinical products encompass drug candidates, therapies, or medical devices in the research and testing stages prior to human clinical trials. These undergo lab and animal testing to evaluate safety, efficacy, and possible side effects. Offered services include biorepository and archiving solutions. Key applications cover research and development, clinical trials, regulatory compliance, and drug development. The solutions serve diverse end users, such as pharmaceutical companies, biotechnology firms, contract research organizations, and academic institutions.

The clinical trial biorepository and archiving solutions market consists of revenues earned by entities by providing services such as long-term archiving, regulatory compliance, data management, inventory tracking and sample retrieval. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical trial biorepository and archiving solutions market also includes sales of cryogenic freezers, biobanking software, automated sample storage systems and liquid nitrogen storage tanks. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.